Growing Through Challenges? – Johnson & Johnson (JNJ)
Currently, there are 2.41B common shares owned by the public and among those 2.40B shares have been available to trade. The company’s stock has a 5-day price change of 2.55% and -9.92% over the past three months. JNJ shares are trading 2.44% year to date (YTD), with the 12-month market performance down to -8.10% lower. […]
Johnson & Johnson (NYSE: JNJ) Seen Running Too Hot, Let’s Look At This More Closely
Currently, there are 2.41B common shares owned by the public and among those 2.40B shares have been available to trade. The company’s stock has a 5-day price change of 0.19% and -9.99% over the past three months. JNJ shares are trading -0.10% year to date (YTD), with the 12-month market performance down to -10.75% lower. […]
Gains May Be On The Menu For Johnson & Johnson (NYSE: JNJ)
Currently, there are 2.41B common shares owned by the public and among those 2.40B shares have been available to trade. The company’s stock has a 5-day price change of -0.78% and -11.55% over the past three months. JNJ shares are trading -8.55% year to date (YTD), with the 12-month market performance down to -8.46% lower. […]
Johnson & Johnson (NYSE: JNJ): Hunting Genuine Value In Market Debris
Currently, there are 2.41B common shares owned by the public and among those 2.40B shares have been available to trade. The company’s stock has a 5-day price change of 0.99% and -10.76% over the past three months. JNJ shares are trading -7.32% year to date (YTD), with the 12-month market performance down to -6.18% lower. […]
Johnson & Johnson (NYSE: JNJ): The Best-Of-Breed For Investing?
Currently, there are 2.41B common shares owned by the public and among those 2.40B shares have been available to trade. The company’s stock has a 5-day price change of -3.84% and -13.90% over the past three months. JNJ shares are trading -8.22% year to date (YTD), with the 12-month market performance down to -8.30% lower. […]
Analyst Expect Big Moves From Johnson & Johnson (NYSE: JNJ)
Currently, there are 2.41B common shares owned by the public and among those 2.40B shares have been available to trade. The company’s stock has a 5-day price change of -3.36% and -10.62% over the past three months. JNJ shares are trading -4.56% year to date (YTD), with the 12-month market performance down to -3.73% lower. […]
Reassessing The Changing Outlook For Johnson & Johnson (JNJ)
Currently, there are 2.41B common shares owned by the public and among those 2.40B shares have been available to trade. Insiders at the company have transacted a total of 11 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 1 of these insider trades were purchases, […]
Analyst Expect Big Moves From Johnson & Johnson (NYSE: JNJ)
Currently, there are 2.61B common shares owned by the public and among those 2.40B shares have been available to trade. Insiders at the company have transacted a total of 35 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 13 of these insider trades were purchases, […]
Johnson & Johnson (NYSE: JNJ): The Best-Of-Breed For Investing?
Currently, there are 2.61B common shares owned by the public and among those 2.40B shares have been available to trade. Insiders at the company have transacted a total of 59 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 25 of these insider trades were purchases, […]
Analyst Expect Big Moves From Johnson & Johnson (NYSE: JNJ)
Capital Research & Management Co recently announced the acquisition of new stake in Johnson & Johnson (NYSE:JNJ). The institutional investor has increased its shareholding in the Healthcare company by 4.17% to 28.99 million shares with purchase of 1.16 million shares. This fresh investment now brings its stake to 1.20% valued currently at $4.54 billion. In […]
